Greylin Investment Management Inc Trims Stake in Cardinal Health, Inc. (NYSE:CAH)

→ Biden replacement revealed? (From Paradigm Press) (Ad)

Greylin Investment Management Inc reduced its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 28.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 28,082 shares of the company's stock after selling 11,190 shares during the quarter. Greylin Investment Management Inc's holdings in Cardinal Health were worth $2,831,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in CAH. Panagora Asset Management Inc. raised its stake in Cardinal Health by 53.6% during the 1st quarter. Panagora Asset Management Inc. now owns 25,616 shares of the company's stock worth $1,452,000 after buying an additional 8,935 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in Cardinal Health by 4.8% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 37,071 shares of the company's stock worth $2,102,000 after buying an additional 1,702 shares during the period. Cibc World Market Inc. bought a new stake in Cardinal Health during the 1st quarter worth approximately $212,000. Blair William & Co. IL increased its holdings in Cardinal Health by 6.7% during the 1st quarter. Blair William & Co. IL now owns 11,769 shares of the company's stock worth $667,000 after purchasing an additional 734 shares in the last quarter. Finally, Sei Investments Co. increased its holdings in Cardinal Health by 6.4% during the 1st quarter. Sei Investments Co. now owns 472,799 shares of the company's stock worth $26,792,000 after purchasing an additional 28,568 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.


Analysts Set New Price Targets

A number of analysts have commented on the company. UBS Group boosted their price objective on Cardinal Health from $122.00 to $125.00 and gave the stock a "buy" rating in a report on Monday, February 5th. Argus raised Cardinal Health from a "hold" rating to a "buy" rating in a report on Friday, February 9th. Barclays assumed coverage on Cardinal Health in a report on Wednesday, January 3rd. They set an "overweight" rating and a $117.00 price objective for the company. Wells Fargo & Company started coverage on Cardinal Health in a report on Thursday, December 14th. They set an "underweight" rating and a $96.00 price objective for the company. Finally, TheStreet lowered Cardinal Health from a "b-" rating to a "c+" rating in a report on Wednesday, December 27th. One research analyst has rated the stock with a sell rating, three have given a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $103.07.

Check Out Our Latest Report on Cardinal Health

Cardinal Health Stock Performance

NYSE CAH traded down $1.40 on Tuesday, hitting $108.07. 1,520,644 shares of the stock traded hands, compared to its average volume of 2,320,019. The business's fifty day moving average is $109.28 and its two-hundred day moving average is $103.34. Cardinal Health, Inc. has a 12 month low of $77.56 and a 12 month high of $116.04. The firm has a market capitalization of $26.29 billion, a price-to-earnings ratio of 42.55, a PEG ratio of 1.06 and a beta of 0.68.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Thursday, February 1st. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.56 by $0.26. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. The business had revenue of $57.45 billion during the quarter, compared to analyst estimates of $57.02 billion. During the same period in the prior year, the company earned $1.32 earnings per share. Cardinal Health's revenue was up 11.6% compared to the same quarter last year. Analysts expect that Cardinal Health, Inc. will post 7.28 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, April 15th. Shareholders of record on Monday, April 1st will be given a dividend of $0.5006 per share. The ex-dividend date of this dividend is Thursday, March 28th. This represents a $2.00 annualized dividend and a dividend yield of 1.85%. Cardinal Health's dividend payout ratio is currently 78.74%.

Cardinal Health Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Articles

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

→ The AI stock to buy right now (From StockEarnings) (Ad)

Should you invest $1,000 in Cardinal Health right now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Featured Articles and Offers

Search Headlines: